• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 17 Results
Document Number CR220436
 
 1 
 2 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas c 303  {Ceruloplasmin} 
CR220436 K062114 Ceruloplasmin General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Prealbumin} 
CR220436 K972638 Prealbumin General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-Quant Haptoglobin Ver.2} 
CR220436 K972639 Haptoglobin General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-quant Transferrin ver.2} 
CR220436 K012371 Transferrin General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-quant Transferrin ver.2 (urine application)} 
CR220436 K182095 Transferrin, urine General Chemistry MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Rheumatoid Factors II} 
CR220436 K032535 Rheumatoid factor (RF) General Immunology MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-Quant Complement C3c ver. 2} 
CR220436 K060373 Complement C3 General Immunology MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-Quant Complement C3c ver. 2} 
CR220436 K012359 Complement C4 General Immunology MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-quant C-Reactive Protein IV} 
CR220436 K192072 C-reactive protein (CRP) General Immunology MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Tina-quant lgA Gen.2} 
CR220436 K040435 Immunoglobulins IgA General Immunology MODERATE 12/05/2022

-
-